A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.
Medscape Medical News
The Prospect of a Medication to Treat OSA Is Getting Closer- The Prospect of a Medication to Treat OSA Is Getting Closer * The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | The Prospect of a Medication to Treat OSA Is Getting Closer | | The Prospect of a Medication to Treat OSA Is Getting Closer | | The Prospect of a Medication to Treat OSA Is Getting Closer | | The Prospect of a Medication to Treat OSA Is Getting Closer |
NEWSHEALTH : The Prospect of a Medication to Treat OSA Is Getting Closer